How many new drugs were detected in Europe over the last year? What are the latest trends in drug production and trafficking? What substances are causing the most concern today?
Find out more when the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) launches its European Drug Report 2023: Trends and Developments in a press conference in Brussels on 16 June at 13:00, live on https://audiovisual.ec.europa.eu/en/ebs/1/20230616
Based on data from 29 countries (EU 27, Türkiye and Norway), the report delivers the latest overview of the drug situation in Europe, exploring long-term trends and emerging threats. The comprehensive analysis covers drug use and supply as well as drug-related harms and responses to them.
The depth and scope of the analysis has been considerably expanded this year, with a wider range of topics covered and in greater detail. For the first time ever, the report is delivered in a new modular, digital-first format, offering innovative ways to access and interact with the content. The resource is designed to be read across a range of devices (PCs, mobiles, tablets) and is available in 25 EU languages.
Over 100 interactive graphics complement the analysis, while dedicated interactive dashboards allow
users to visualise data and trends at European and national level. Data journalists and researchers
will be able to access the underlying data for easier sharing and re-use. Accompanying the report is the
2023 Statistical Bulletin containing national datasets.
About the event
Date: 16 June 2023 at 12.00 (Lisbon), 13.00 CET (Brussels).
Venue: European Commission, Berlaymont, VIP corner. The event will be live streamed on Europe by Satellite.
- Ylva Johansson, European Commissioner for Home Affairs
- Alexis Goosdeel, EMCDDA Director